title: In Reply: Statistical Power to Detect an Association Between Guideline-based Palivizumab Administration and Hospitalizations for Respiratory Syncytial Virus Infections.
authors.affiliation: Department of Pharmacy, Sanford Medical Center, Fargo, North Dakota.
authors.forename: Carlina J
authors.initials: CJ
authors.lastname: Grindeland
authors.forename: David D
authors.initials: DD
authors.lastname: Leedahl
mesh_terms: D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D006760:Hospitalization; D006801:Humans; D007223:Infant; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections
chemical_list: D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D000069455:Palivizumab